Understanding how RNA interacting proteins modulate the translatability of mRNAs

Lead Research Organisation: University of Manchester
Department Name: Life Sciences

Abstract

Cells are governed by their genomes, the genetic blueprint for all the gene products (proteins and RNAs) that carry out the myriad of biological functions that underpin life. Understanding the 'parts list' is however, only the first necessary step towards a complete understanding of how cells work. Complex behaviours such as responding to environmental stimuli, growing and dividing, or differentiating and specialising into a given tissue are tightly regulated. This is achieved by controlling when genes are turned 'on' and 'off', often in complex pathways and networks. We now know that there are several important control points in the process of gene regulation, as changes in temperature, nutrients and other factors in the environment influence how cells behave. This proposal focuses on one group of proteins that are required to make (or synthesize) all new proteins in each cell, a process referred to as 'translation'. These 'protein synthesis factors' translate RNA, a messenger molecule that encode gene sequences, into protein molecules. There are many thousands of RNA molecules in each cell, each one carrying instructions (or coding) for a different protein. The protein synthesis factors must interact with each RNA in the right way so that each new protein is made correctly and in the correct proportions. By improving our fundamental understanding of how such processes work in normal cells it can help scientists understand diseases in which this process is altered, or how agents such as viruses are able to hijack plant, animal or human cells and cause infectious diseases. In this proposal we address the broad question of how is it that the protein synthesis factors know which RNAs to decode at any one time? We and others have found that the abundance of each different RNA present is a poor predictor for the abundance of the protein that it encodes. This means that there must be an active choice or selection process to pick which RNAs are to be translated at any one time. For a few RNAs it is known that they contain specific elements that help control their use. Also that there are other proteins present in cells that can bind to RNAs to influence where and when they are used. However at the present time very few details are known for almost all RNAs even within the simplest cells. In this proposal we will address this issue using the genetically amenable single celled organism bakers and brewers yeast (Saccharomyces cerevisae). We will take a broad approach using modern technologies to study proteins that interact with RNAs to control when they are translated. We will then follow this by picking specific examples to study in greater mechanistic detail. We will provide evidence for which RNAs are controlled by which set of protein factors and which are important for responding to specific stress conditions.

Technical Summary

Our goals are to define, on a global scale, novel mechanisms of translational control in eukaryotes. As an experimentally amenable model system, we are studying how Saccharomyces cerevisiae cells respond to defined stresses. Our work leading to this proposal has shown that yeast cells down-regulate the translation of most genes in response to the stresses of amino acid starvation, oxidative stress or addition of fusel alcohols, by targeting and down-regulating the translation initiation factor eIF2B. By applying microarray techniques to examine the level of ribosome association of each mRNA we found that many hundreds of individual mRNAs are resistant to the global trend and are actively translated during these stresses. Although all three stresses target eIF2B, the individual genes that remain active are to a large extent specific to the stress imposed. Yet they share some common properties (e.g longer 5' UTR length). These data demonstrate that factors other than eIF2B must be important for determining how individual mRNAs respond to these stresses. We propose here a large genome-wide study that will draw upon our combined expertise to use a concerted set of techniques to characterise regulated mRNAs and the protein partners that mediate their control in response to these three different stress regimens. Central to our analysis strategy is a requirement for advanced informatics analyses to identify common features shared by co-regulated RNAs. Taken as a whole, a strength of this programme is that it will provide a large body of directly comparable functional genomics data. In addition, we will develop models for novel translational control mechanisms that we will then test experimentally on specific selected mRNAs. By these approaches we aim to achieve a step-change improvement in understanding of translation controls in yeast, which will inform studies in other organisms and be of interest to a wide group of beneficiaries.

Publications

10 25 50

 
Description Cells are governed by their genomes, the genetic blueprint for all the gene products (proteins and RNAs) that carry out the myriad of biological functions that underpin life. Understanding the parts list is, however, only the first necessary step towards a complete understanding of how cells work. Complex behaviours such as responding to environmental stimuli, growing and dividing, or differentiating and specialising into a given tissue are tightly regulated. This is achieved by controlling when genes are turned on and off, often in complex pathways and networks. We now know that there are several important control points in the process of gene regulation, as changes in temperature, nutrients and other factors in the environment influence how cells behave. This proposal focuses on one group of proteins that are required to make (or synthesize) all new proteins in each cell, a process referred to as "translation". These 'protein synthesis factors' translate RNA, a messenger molecule that encode gene sequences, into protein molecules. There are many thousands of RNA molecules in each cell, each one carrying instructions (or coding) for a different protein. The protein synthesis factors must interact with each RNA in the right way so that each new protein is made correctly and in the correct proportions. By improving our fundamental understanding of how such processes work in normal cells it can help scientists understand diseases in which this process is altered, or how agents such as viruses are able to hijack plant, animal or human cells and cause infectious diseases.
In this proposal we addressed the broad question of how protein synthesis factors know which mRNAs to decode at any one time? We and others have found that the abundance of each different RNA present is a poor predictor for the abundance of the protein that it encodes. This means that there must be an active choice or selection process to pick which RNAs are to be translated at any one time. For a few RNAs it is known that they contain specific elements that help control their use. Also that there are other proteins present in cells that can bind to RNAs to influence where and when they are used. However at the present time very few details are known for almost all RNAs even within the simplest cells. We addressed this issue using the genetically amenable single celled organism bakers and brewers yeast (Saccharomyces cerevisae). We have made several discoveries which show:
That a key initiation factor complex that binds to the 5'end of mRNAs shows binding preferences and its association varies between mRNAs. That changes in the complex interactions with mRNAs occur follwoing acute stress that is similar across mRNAs and stresses and appears opposite to current models of translation initiation.
That the 4E-BPs, proteins thought of as translational repressors can bind to ribosomes and to specific mRNAs independent of eIF4E the their major binding partner.
That the mRNA/ribosome binding proteins PUF3 and SLF1 regulate translation in response to oxidative stress. That each binds specific mRNAs
Exploitation Route We are in discussions with biotech companies, but this remains ongoing.
Sectors Healthcare

Manufacturing

including Industrial Biotechology

 
Description Responsive mode grant
Amount £392,020 (GBP)
Funding ID BB/N014049/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 11/2016 
End 10/2019